Details for Patent: 5,208,256

Summary for Patent: 5,208,256

Title:	Treatment of ocular hypertension with a synergistic combination for ocular administration
Abstract:	A method for treatment of ocular hypertension which comprises ocularly administering, to a subject in need of such treatment, an oculo-hypotensively synergistic combination of (a) a 13,14-dihydro-15-keto-20-loweralkylprostaglandin or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable ester thereof, and (b) a polyoxyethylenesorbitan unsaturated higher aliphatic acid monoester in an amount effective in treatment of ocular hypertension.
Inventor(s):	Ueno; Ryuji (Hyogo, JP)
Assignee:	R-Tech Ueno, Ltd. (Osaka, JP)
Application Number:	07/703,660
Patent Claim Types: see list of patent claims	Use; Composition;

Drugs Protected by US Patent 5,208,256

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: 5,208,256

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Japan	2-132909	May 22, 1990

International Family Members for US Patent 5,208,256

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	114470
Canada	2042972
Germany	69105349
Denmark	0458588
European Patent Office	0458588
Spain	2067864